Author:
Bloom Diane,Beetsch Joel,Harker Matthew,Hesterlee Sharon,Moreira Paulo,Patrick-Lake Bray,Selig Wendy,Sherman Jeffrey,Smith Sophia K.,Valentine James E.,Roberts Jamie N.
Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference15 articles.
1. US Food and Drug Administration. Patient-focused drug development. http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm347317.htm. Accessed June 17, 2015.
2. Albarracin D, Gillette JC, Earl AN, Glasman LR, Durantini MR, Ho MH. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull. 2005;131:856–897.
3. Parsons S, Starling B, Mullan-Jensen C, Tham S-G, Warner K, Wever K. What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries. BMJ Open. 2015;5.
4. Pushparajah DS, Geissler J, Westergaard N. EUPATI: collaboration between patients, academia and industry to champion the informed patient in the research and development of medicines. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwifr5TQkZjUAhXGKCYKHaBjA1UQFggkMAA&url=https%3A%2F%2Fwww.eupati.eu%2Fwp-content%2Fuploads%2F2016%2F09%2F2015-07-Journal-Med-Dev-Sciences-EUPATI-Collaboration-between-patients-academia-industry_EN.pdf&usg=AFQjCNGlYRt2IlhBs758wOmeL-N5974yYg&sig2=hIwnuY4eKDavpzP0ncA7kg&cad=rja. Accessed May 30, 2017.
5. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines. Therapeutic Innovation & Regulatory Science. 2015;49:929–939.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献